DrugPatentWatch Database Preview
Details for Patent: 8,128,960
Which drugs does patent 8,128,960 protect, and when does it expire?
This patent has twenty patent family members in nineteen countries.
Summary for Patent: 8,128,960
Title: | Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
Abstract: | Triamcinolone acetonide suspension compositions are disclosed. The suspension compositions have a relatively low viscosity and are easy to extrude through a 27- or 30-gauge needle but are highly flocculated and easily redispersed. The compositions are particularly suitable for intravitreal injection. |
Inventor(s): | Kabra; Bhagwati P. (Euless, TX), Sarkar; Ruma (Fort Worth, TX) |
Assignee: | Alcon Research, Ltd. (Fort Worth, TX) |
Application Number: | 12/401,168 |
Patent Claim Types: see list of patent claims | Composition; Compound; Formulation; |
Drugs Protected by US Patent 8,128,960
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis Pharms Corp | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 8,128,960
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
8,211,880 | Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection | ➤ Sign Up |
Patent No. | Title | Estimated Patent Expiration |
International Patents Family Members for US Patent 8,128,960
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Taiwan | I468165 | ➤ Sign Up | |||
Taiwan | 200940071 | ➤ Sign Up | |||
Slovenia | 2262506 | ➤ Sign Up | |||
Russian Federation | 2481842 | ➤ Sign Up | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |